Key result
XGBoost model detects depressive symptoms in chronic digestive disease patients with ~0.79 AUROC.
Why the study?
Chronic digestive system diseases are common in older adults, and depressive symptoms are associated with poorer prognosis and quality of life.
Can a machine-learning model accurately identify prevalent depressive symptoms in patients with chronic digestive system diseases?
Cross-Sectional (n=3,762)
Yes
Can a machine-learning model accurately identify prevalent depressive symptoms in patients with chronic digestive system diseases?
Effect estimate: AUROC 0.793 (95% CI 0.767-0.816)
An XGBoost machine-learning model using 13 routinely collected variables can effectively screen for depressive symptoms in patients with chronic digestive system diseases.
May support ML screening for depression in CDSD; hypothesis-generating and requires prospective validation before clinical use.
Chronic digestive system diseases (CDSD) are common in older adults, and depressive symptoms are associated with poorer prognosis and quality of life. We developed a machine-learning screening model to identify prevalent depressive symptoms in individuals with CDSD using data from the China Health and Retirement Longitudinal Study (CHARLS). This study included 3762 participants with CDSD from the 2011 survey and examined 45 behavioral, health, psychological, and sociodemographic variables. Feature selection was performed using logistic regression and LASSO regression, and seven modeling approaches were compared. Temporal validation was conducted in participants who newly reported physician-diagnosed CDSD in the 2015 CHARLS wave, with model inputs and depressive symptoms measured in the same wave. Among 3762 participants, 1900 had depressive symptoms. Thirteen variables were retained, including education, residence, life assessment, health assessment, fall history, disability, kidney disease, arthritis, heart disease, eyesight, instrumental activities of daily living, sleep duration, and grip strength. XGBoost was selected as the final model, achieving an area under the curve of 0.793 and an F1-score of 0.724 in the testing set, with acceptable calibration. These findings suggest that machine-learning approaches may support preliminary screening of existing depressive symptoms in people with CDSD.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) conducted a cross-sectional in Chronic digestive system diseases and depressive symptoms (n=3,762). 13-feature XGBoost machine-learning screening model was evaluated on Model performance (AUROC) for identifying depressive symptoms in the testing set (AUROC 0.793, 95% CI 0.767-0.816). An XGBoost machine-learning model incorporating 13 routine clinical and sociodemographic variables identified prevalent depressive symptoms in patients with chronic digestive system diseases with an AUROC of 0.793.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: